Orthofix Medical (OFIX) Receivables (2010 - 2026)

Orthofix Medical has disclosed Receivables across 17 years of filings, most recently posting $137.8 million for Q1 2026.

• Quarterly Receivables rose 4.48% year-over-year to $137.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.8 million (up 4.48% YoY) and the FY2025 annual result came in at $135.7 million, up 0.77% from the prior year.
• Receivables improved to $137.8 million in Q1 2026, from $135.7 million in the prior quarter.
• Over five years, Receivables peaked at $137.8 million in Q1 2026 and troughed at $72.5 million in Q1 2022.
• A 5-year average of $114.8 million and a median of $125.4 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables surged 56.37% — and 2025, when it gained 0.77%.
• Tracing OFIX's Receivables over 5 years: stood at $82.9 million in 2022, then surged by 54.6% to $128.1 million in 2023, then gained by 5.16% to $134.7 million in 2024, then grew by 0.77% to $135.7 million in 2025, then increased by 1.49% to $137.8 million in 2026.
• Business Quant data shows OFIX's Receivables at $137.8 million in Q1 2026, $135.7 million in Q4 2025, and $130.8 million in Q3 2025.